Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities      
Net income (loss) $ 2,498 $ 1,630 $ 1,183
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization expense 634 557 551
Amortization of debt issuance costs, premium and discount 30 29 32
Loss on modification or extinguishment of debt 33 101 43
Total losses (gains) on derivative instruments, net 1,158 (29) 49
Total gains on derivatives instruments, net—related party 0 (2) 0
Net cash used for settlement of derivative instruments (102) (17) (4)
Other 44 27 19
Other—affiliate 0 0 (2)
Changes in operating assets and liabilities:      
Trade and other receivables, net of current expected credit losses (112) (204) (21)
Accounts receivable—affiliate (335) (32) (80)
Accounts receivable—related party 0 (1) 0
Advances to affiliate (36) 2 8
Inventory 12 (68) 8
Margin deposits (28) (3) (2)
Accounts payable and accrued liabilities 354 321 0
Accrued liabilities—related party 3 (1) 4
Due to affiliates 20 1 9
Deferred revenue (11) 18 (18)
Other, net 24 38 26
Other, net—affiliate 11 0 2
Net cash provided by operating activities 4,149 2,291 1,751
Cash flows from investing activities      
Property, plant and equipment (451) (648) (972)
Net cash used in investing activities (451) (648) (972)
Cash flows from financing activities      
Proceeds from issuances of debt 559 3,182 1,995
Redemptions and repayments of debt (1,560) (3,600) (2,000)
Debt issuance and other financing costs (7) (39) (35)
Debt extinguishment costs (32) (76) (39)
Distributions (2,635) (1,451) (1,359)
Other (1) 8 4
Net cash used in financing activities (3,676) (1,976) (1,434)
Net increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents 22 (333) (655)
Cash, Cash Equivalents—beginning of period 974 1,307 1,962
Cash, Cash Equivalents—end of period $ 996 $ 974 $ 1,307